Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00629265 · ClinicalTrials.gov registry record · NA
Efficacy of Electrical Stimulation for Dysphagia in Head & Neck Cancer Patients
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 170
- Enrollment target
NCT00629265: Completed NA study, sponsored by Boston Medical Center.
NCT00629265 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 170 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00629265, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
Study Summary
The purpose of the investigation is to learn whether intense swallowing exercise or intense swallowing exercise coupled with electrical stimulation (E-Stim) helps patients who had head/neck cancer and currently have dysphagia swallow better.
Primary Outcome
The PAS scale is a validated 8-point ordinal scale (Rosenbek et. al 1996) in which a score of 1 is best (material does not enter the airway) and a score of 8 is worst (material enters the airway, passes below the vocal folds, and no effort is made to eject it). Difference in mean PAS scores after 12 weeks of therapy was analyzed between the two groups of interest: Active NMES + Swallowing Exercise versus Sham (inactive) NMES + Swallowing Exercise. PAS scores were obtained from fluoroscopy (modi
Interventions
- DEVICE Neurotech NT2000 Neuromuscular Electrical Stimulation (NMES)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2008-03 |
| Est. Completion | 2013-05 |
| Phase | NA |
What the finished NCT00629265 record still lists
NCT00629265 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which Neurotech NT2000 Neuromuscular Electrical Stimulation (NMES) is the first listed.
NCT00629265 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00629265 about?
NCT00629265 is a clinical study titled "Efficacy of Electrical Stimulation for Dysphagia in Head & Neck Cancer Patients". The purpose of the investigation is to learn whether intense swallowing exercise or intense swallowing exercise coupled with electrical stimulation (E-Stim) helps patients who had head/neck cancer and currently have dysphagia swallow better.
What is the current status of trial NCT00629265?
This trial is currently completed. It is a NA study. The enrollment target is 170 participants. The study started on 2008-03. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00629265?
The interventions under investigation include: Neurotech NT2000 Neuromuscular Electrical Stimulation (NMES) (DEVICE).
Who is sponsoring clinical trial NCT00629265?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00629265's enrollment target sits among peer trials
170 614th of 2000 higher than 1,382 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia